Pages with the fewest revisions
Appearance
Showing below up to 50 results in range #251 to #300.
- Phentermine (2 revisions)
- Effect:Autonomous voice communication (2 revisions)
- Effect:Dehydration (2 revisions)
- Phenotype:CYP3A4 intermediate metabolizer (2 revisions)
- Effect:Double vision (2 revisions)
- Phenotype:CYP2C19 poor metabolizer (2 revisions)
- Meloxicam (2 revisions)
- Effect:Color shifting (2 revisions)
- Problem:Agoraphobia (2 revisions)
- Effect:Optical sliding (2 revisions)
- Problem:Hoarding Disorder (2 revisions)
- Ivermectin (2 revisions)
- Effect:Serious cardiac event (2 revisions)
- Problem:Cyclothymic Disorder (2 revisions)
- Effect:Peripheral vasculopathy (2 revisions)
- Problem:Hangover (2 revisions)
- Sodium Chloride (2 revisions)
- Effect:Auditory distortion (2 revisions)
- Problem:Psoriasis (2 revisions)
- Dexamethasone (2 revisions)
- Effect:Environmental orbism (2 revisions)
- Problem:Dependent Personality Disorder (2 revisions)
- Effect:Brightness alteration (2 revisions)
- Penicillin G (2 revisions)
- Dicyclomine (2 revisions)
- Effect:Personality regression (2 revisions)
- Problem:Embarrassment (2 revisions)
- Telmisartan (2 revisions)
- Chlorthalidone (2 revisions)
- Effect:Anticholinergic effects (2 revisions)
- Problem:Avoidant/Restrictive Food Intake Disorder (2 revisions)
- Insulin Degludec (2 revisions)
- Effect:Personal bias suppression (2 revisions)
- Problem:Alzheimer disease (2 revisions)
- Atorvastatin (2 revisions)
- Effect:Perception of predeterminism (2 revisions)
- Problem:Cardiovascular risk reduction in obesity (2 revisions)
- Sucralfate (2 revisions)
- Effect:Personal meaning intensification (2 revisions)
- Effect:Diarrhea (2 revisions)
- Bimatoprost (2 revisions)
- Effect:Neuroplasticity (2 revisions)
- Effect:Anxiolysis (2 revisions)
- Linaclotide (2 revisions)
- Effect:External auditory hallucination (2 revisions)
- Effect:Photophobia (2 revisions)
- Phenotype:NUDT15 normal metabolizer (2 revisions)
- Dapagliflozin (2 revisions)
- Effect:Color tinting (2 revisions)
- Phenotype:CYP2C9 poor metabolizer (2 revisions)